Effect of cyclic adenosine monophosphate on the G protein-dependent inward rectifier K+-like channel current in medial prefrontal cortex pyramidal neurons

Journal of Physiology and Pharmacology

Volumn 63, Issue 5, 2012, Pages 457-462

  Witkowski, G ^a   Rola, R ^a   Szulczyk, P ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Channel currents; Cyclic adenosine monophosphate; G protein dependent inward rectifier K+; Medial prefrontal cortex; Protein kinase A; Pyramidal neurons

Indexed keywords

8 (4 CHLOROPHENYTHIO) 2' O METHYLADENOSINE 3',5' CYCLIC MONOPHOSPHATE SODIUM; 8 BROMO CYCLIC AMP; CHEMICAL COMPOUND; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; KT 5720; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; MALE; MEMBRANE PERMEABILITY; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PREFRONTAL CORTEX; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; RAT;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FORSKOLIN; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; MALE; PREFRONTAL CORTEX; PYRAMIDAL CELLS; RATS; RATS, WISTAR;

EID: 84870616710     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Korf S, Stein DJ, Harvey BH. Cortico-striatal cyclic AMP-phosphodiesterase-4 signalling and stereotypy in the deer mouse: attenuation after chronic fluoxetine treatment. Pharmacol Biochem Behav 2009; 92: 514-520.
2. Pain TA, Neve RL, Carlezon Jr WA. Attention deficit disorder and hyperactivity following inhibition of cAMP dependent protein kinase within the medial prefrontal cortex of rats. Neuropsychopharmacology 2009; 34: 2143-2155.
3. Wan L, Su L, Xie X, Liu Y, Wang Y, Wang Z. Protein receptor for activated C kinase 1 is involved in morphine reward in mice. Neuroscience 2009; 161: 734-742.
4. Raiteri M. Functional pharmacology in human brain. Pharmacol Rev 2006; 58: 162-193.
5. + channel mRNAs are differentially expressed in the adult rat brain. J Neurosci 1996; 16: 3559-3570.
6. + channels. Cell Signal 1997; 9: 551-573.
7. + channels by ifenprodil. Neuropsychopharmacology 2006; 31: 516-524.
8. + channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons. Neuron 1997; 19: 687-695.
9. Rossi P, Mapelli L, Roggeri L, et al. Inhibition of constitutive inward rectifier currents in cerebellar granule cells by pharmacological and synaptic activation of GABA receptors. Eur J Neurosci 2006; 24: 419-432.
10. Witkowski G, Szulczyk B, Rola R, Szulczyk P. D1 dopaminergic control of GIRK-like channel current in pyramidal neurons of the medial prefrontal cortex. Neuroscience 2008; 155: 53-63.
11. Medina I, Krapivinsky G, Arnold S, Kovoor P, Krapivinsky L, Clapham DE. A switch mechanism for Gbetagamma activation of Ik. Arch J Biol Chem 2000; 275: 29709-29716.
12. + channels by β-adrenergic stimulation via cAMP-dependent protein kinase. J Gen Physiol 2000; 115: 547-558.
13. Yamada M, Inanobe A, Kurachi Y. G protein regulation of potassium ion channels. Pharmacol Rev 1998; 50: 723-757.
14. Brown SG, Thomas A, Dekker L, Tinker A, Leaney JL. PKC-δ sensitizes Kir3.1/3.2 channels to changes in membrane phospholipid levels after M3 receptor activation in HEK-293 cells. Am J Physiol Cell Physiol 2005; 289: C543-C556.
15. 2+ independent protein kinase. J Physiol 2001; 534: 367-379.
16. + channels by protein kinase C. Proc Natl Acad Sci USA 2004; 101: 1087-1092.
17. Nikolov EN, Ivanova-Nikolova TT. Coordination of membrane excitability through a GIRK1 signaling complex in the atria. J Biol Chem 2004; 279: 23630-23636.
18. + (GIRK) channel current in rat atrial myocytes. J Physiol 2008; 586: 2049-2060.
19. Muellner C, Yakubovich D, Dessauer CW, Platzer D, Schreibmayer W. Single channel analysis of the regulation of GIRK1/GIRK4 channels by protein phosphorylation. Biophys J 2003; 84: 1399-1409.
20. Ongur D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex 2000; 10: 206-219.
21. Witkowski G, Szulczyk P. Opioid mu receptor activation inhibits sodium currents in prefrontal cortical neurons via a protein kinase A-and C-dependent mechanism. Brain Res 2006; 1094: 92-106.
22. Dong Y, Cooper D, Nasif F, Hu X, White FJ. Dopamine modulates inwardly rectifying potassium currents in medial prefrontal cortex pyramidal neurons. J Neurosci 2004; 24: 3077-3085.
23. Dong Y, Nasif FJ, Tsui JJ, et al. Cocaine-induced plasticity of intrinsic membrane properties in prefrontal cortex pyramidal neurons: adaptations in potassium currents. J Neurosci 2005; 25: 936-940.
24. Maurice N, Tkatch T, Meisler M, Sprunger LK, Surmeier DJ. D1/D5 dopamine receptor activation differentially modulates rapidly inactivating and persistent sodium currents in prefrontal cortex pyramidal neurons. J Neurosci 2001; 21: 2268-2277.
25. Peterson JD, Wolf ME, White FJ. Repeated amphetamine administration decreases D1 dopamine receptor-mediated inhibition of voltage-gated sodium currents in the prefrontal cortex. J Neurosci 2006; 26: 3164-3168.
26. + channels in dendrites of hippocampal CA1 pyramidal neurons. J Neurosci 2005; 25: 3787-3792.
27. Voigt N, Maguy A, Yeh Y, et al. Changes in IK,ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes. Cardiovasc Res 2008; 77: 35-43.
28. Holz GG, Kang G, Harbeck M, Roe MW, Chepurny OG. Cell physiology of cAMP sensor Epac. J Physiol 2006; 577: 5-15.
29. Li Z, Ji G, Neugebauer V. Mitochondrial reactive oxygen species are activated by mGluR5 through IP3 and activate ERK and PKA to increase excitability of amygdala neurons and pain behavior. J Neurosci 2011; 31: 1114-1127.
30. Nakamura K, Hirano J, Kubokawa M. An ATP-regulated and pH-sensitive inwardly rectifying K(+) channel in cultured human proximal tubule cells. Jpn J Physiol 2001; 51: 523-530.
31. Fu Y, Neugebauer V. Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior. J Neurosci 2008; 28: 3861-3876.
32. Yao L, Sakaba T. Activity-dependent modulation of endocytosis by calmodulin at a large central synapse. Proc Natl Acad Sci USA 2012; 109: 291-296.
33. Baddeley AD, Hitch GJ. Working memory. In: The Psychology of Learning and Motivation, GA Bower (ed.), Academic Press, 1974, pp 47-89.
34. Ciecko-Michalska I, Wojcik J, Wyczesany M, et al. Cognitive evoked response potentials in patients with liver cirrhosis without diagnosis of minimal or overt hepatic encephalopathy. A pilot study. J Physiol Pharmacol 2012; 63: 271-276.
35. Hains AB, Arnsten AFT. Molecular mechanisms of stress-induced prefrontal cortical impairment: Implications for mental illness. Learn Mem 2008; 15: 551-564.
36. Panegyres PK. The contribution of the study of neurodegenerative disorders to the understanding of human memory. QJM 2004; 97: 555-567.
37. O'Donnell P. Dopamine gating of forebrain neural ensembles. Eur J Neurosci 2003; 17: 429-435.
38. Aujla H, Beninger RJ. Hippocampal-prefrontocortical circuits: PKA inhibition of the prefrontal cortex impairs delayed non matching in the radial maze in rats. Behav Neurosci 2001; 115: 1204-1211.
39. Taylor JR, Birnbaum S, Ubriani R, Arnsten A. Activation of cAMP-dependent protein kinase A in prefrontal cortex impairs working memory performance. J Neurosci 1999; 19: 23.
40. Huang CW, Tsai JJ, Huang CC, Wu SN. Experimental and simulation studies on the mechanisms of levetiracetam-mediated inhibition of delayed-rectifier potassium current (KV3.1): contribution to the firing of action potentials. J Physiol Pharmacol 2009; 60: 37-47.
41. Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 2011; 63: 182-217.
42. Williams JT, Christie MJ, Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 2001; 81: 299-343.
43. Cato AC, Nestl A, Mink S. Rapid actions of steroid receptors in cellular signaling pathways. Sci STKE 2002; 2002 (138): re9.
44. Pineyro G, Blier P. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol Rev 1999; 51: 533-591.
45. Ruat M, Traiffort E, Leurs R, et al. Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc Natl Acad Sci USA 1993; 90: 8547-8551.
46. Tokarski K, Kusek M, Hess G. 5-HT7 receptors modulate GABAergic transmission in rat hippocampal CA1 area. J Physiol Pharmacol 2011; 62: 535-540.